Home » Blog » Company News

Company News

  • Suspiriosis et Allergy Drug Development nimium saepe deficit - Reset translational opus est: HKEY-AIRx™ 1.0

    2026-02-03

    BOSTON et SUZHOU, China, die 27 Jan. 2026 /PRNewswire/ -- HKeyBio, preclinical CRO in autoimmune et allergico morbo pharmaci progressus, hodie denuntiavit consilium translationale preclinicalis, HKEY-AIRxTM1.0 destinatum est ad unum e quaestionibus pertinacissimis quae ad ductionem biotechicam spectantes: quare Read More
  • HKeyBio Launches HKEY-AIDMD 3.0--a Postera generatio rostris resiliunt durior provocatio in autoimmune et allergia medicamento Development: Multi-scopum deducto Strategy Optimization

    2026-02-03

    Nuper upgraded HKEY-AIDMD 3.0 exemplar bibliothecae lineamenta 300 fere autoimmune et morborum exempla allergia relatas. Pro multis maioribus indiciis, HKeyBio quattuor dimensiones (4D) exemplar lacus statuit quae heterogeneitatem clinicam simulant, dum mechanismum agitatae exemplar lectionis suggestum praebet. Read More
  • HKeyBio deducta maxime Comprehesive Primas Autoimmune & Allergic Morbus Non humano Exemplar Matrix Ad Redefining Volume Translation

    2026-02-03

    BOSTON et SUZHOU, China, 23 Sept. 2025 / PRNewswire/ -- HKeyBio, CRO specialiter in praeclinicali et translationali autoimmune-medicamento progressus, hodie denuntiavit launchem HKEY-NHP-MATRIX2.0, suggestum proximum generationis destinatum ad emendandam fidem mutandi autoimmune et omnia nova. Read More
  • CIA Model: Clavis revelandi Mechanismi Multisystem Damnum in Rheumatoid Arthritis

    2025-07-31

    CIA exemplar: Clavis ad detegendo Mechanismum Multisystem Damnum in arthritis arthritisRheumatoidei rheumatoidei (RA) non est tantum deordinatio artuum circumscripta; complexus est, inflammatoriae longi conditiones longe attingentes. Read More
  • CIA Model: Innovative applications of Collagen II Inductus

    2025-07-24

    CIA Model: Innovative applications of Collagen II InducedIn dynamicam campum vitae scientiae investigationis, constructio morborum exempla veluti cardo angularis stat. Read More
  • CIA Model: A key tool pro analyzing Autoimmune Response

    2025-07-17

    CIA Model: Clavis instrumentum ad analysendum autoimmune ResponseAutoimmune morborum, notatum ab oppugnatione immune systematis abnormis in propria corporis fibras, facta est provocatio globalis sanitatis. Read More
  • CIA Model: Core tool pro Insights in Synovialis Inflammatio

    2025-07-11

    CIA exemplar: Instrumentum Core Insights Synovialis InflammatioSynovialis inflammatio consecuta, communis processus pathologicus in arthritis autoimmune et aliis morbis articulariis affinibus, significantem comminationem ad salutem humanam proponit. Read More
  • Profunda Dive in Societas inter CIA Model et Articulus Perditio

    2025-07-07

    Alta Dive in Associationem inter CIA exemplar et Coniunctionis Destructionem Coniunctio, consequentia vastans in morbis autoimmunes sicut arthritis rheumatoidis, signanter mobilitatem aegrorum imminuit. Read More
  • Quomodo Pso Model Acta Psoriatic Arthritis Research?

    2024-11-08

    IntroductionPsoriatic Arthritis (PsA) est arthritis inflammatione associata cum conditione cutis Psoriasis. Ad damnum iuncturam ducere potest et notabilem ictum in qualitate aegrorum vitae. Incomplexitas PsA, cum pathogenesis multifaceta implicat geneticam, immunologicam et envi . Read More
  • Summa 3 paginarum Go to Page
  • Go
HKeybio est contractus Research Organizatio (CRO) specialis in investigationibus preclinicis intra campum morborum autoimmunerum.

Velox Vincula

Service Catagory

Contact Us

Phone  ​
Negotium Procurator-Julie Lu:+86- 18662276408
Negotium Inquisitionis-Will Yang:+86- 17519413072
Consultatio Technical-Evan Liu:+86- 17826859169
nobis. bd@hkeybio.com; feugiat. bd@hkeybio.com; uk. bd@hkeybio.com .
Add   : Aedificium B, No.388 Xingping Street, Ascendas iHub Suzhou Industrial Park, JIANGSU, CHINA
Aliquam Nuntius
Contact Us
Subcribo sursum pro nostro tabellario ad novissimum nuntium recipiendum.
Copyright © 2024 HkeyBio. All rights reserved. | Sitemap | Privacy Policy